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Abstract
Background: Cul1 is a core component of the evolutionarily conserved SCF-type ubiquitin ligases
that target specific proteins for destruction. SCF action contributes to cell cycle progression but
few of the key targets of its action have been identified.
Results: We found that expression of the mouse Cul1 (mCul1) in the larval wing disc has a
dominant negative effect. It reduces, but does not eliminate, the function of SCF complexes,
promotes accumulation of Cubitus interruptus (a target of SCF action), triggers apoptosis, and
causes a small wing phenotype. A screen for mutations that dominantly modify this phenotype
showed effective suppression upon reduction of E2F function, suggesting that compromised
downregulation of E2F contributes to the phenotype. Partial inactivation of Cul1 delayed the abrupt
loss of E2F immunofluorescence beyond its normal point of downregulation at the onset of S phase.
Additional screens showed that mild reduction in function of the F-box encoding gene slimb
enhanced the mCul1 overexpression phenotype. Cell cycle modulation of E2F levels is virtually
absent in slimb mutant cells in which slimb function is severely reduced. This implicates Slimb, a
known targeting subunit of SCF, in E2F downregulation. In addition, Slimb and E2F interacted in vitro
in a phosphorylation-dependent manner.
Conclusion: We have used genetic and physical interactions to identify the G1/S transcription
factor E2F as an SCFSlmb target in Drosophila. These results argue that the SCFSlmb ubiquitin ligase
directs E2F destruction in S phase.
Background
The ubiquitin-proteasome pathway is essential for degra-
dation of many regulatory proteins. Proteins are targeted
for proteasome-mediated degradation by attachment of a
polyubiquitin chain. The addition of a polyubiquitin
chain to a protein requires the sequential action of a ubiq-
uitin-activating enzyme (E1), a ubiquitin-conjugating
enzyme (E2) and a ubiquitin-protein ligase (E3) [1]. E3
activities are thought to be essential because they are
involved in substrate recognition. SCF complexes are E3s
composed of the Cullin family member Cul1 (Cdc53 in S.
cerevisiae), as well as, Skp1, Roc1 (also called Rbx1 or
Hrt1) and one of the numerous F-box proteins that act as
a receptor for the substrate (for review see [2]).
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identified through genetic analysis of the G1/S transition
in budding yeast and served as a model for the study of
other SCF complexes. Mutations in the E2 enzyme Cdc34
or in any of the SCFCdc4 components (Cdc53/Cul1, Skp1
and Cdc4) arrest cells at the G1/S transition because of a
failure to degrade the cyclin-dependent kinase (CDK)
inhibitor Sic1 [3][4]. In a wild-type situation, G1 cyclin/
CDK complexes phosphorylate Sic1 at the end of G1. This
leads to Cdc34-dependent ubiquitination and degrada-
tion of Sic1. Phosphorylated Sic1, but not the unmodified
protein, is recruited to the SCF complex by binding to the
WD domain of Cdc4 [5][6]. The F-box motif of Cdc4
binds Skp1 so that the F-box protein acts as a bridge
between substrate and the SCF complex. Cdc53 forms the
core of the complex by binding Skp1, Roc1 and Cdc34.
The Cdc53/Roc1 subcomplex stimulates the ubiquitina-
tion activity of Cdc34 [7][8]. Upon association with the
complex, Sic1 is extensively ubiquitinated and then
degraded by the proteasome. While mutations in the
CDC53 gene of S. cerevisiae eliminate SCF activity toward
its many diverse targets, the phenotype is nonetheless spe-
cific. Presumably, arrest at the G1/S transition is a result of
the thresholds and kinetics of action of the various sub-
strates, which imparts special importance to the targeting
of Sic1 for degradation. Mutations in the C. elegans
ortholog Cul1 lead to increased cell number [9] showing
that in this organism a different aspect of cell cycle regula-
tion is controlled in a Cul1 dependent fashion. It has been
inferred that a deficit in Cul1 function results in defects in
turn-over of specific proteins and that the phenotype var-
ies between systems because of differences in the spec-
trum of proteins affected and differences in the
importance of the targeted proteins.
The transcription factor E2F is an important regulator of
the G1/S phase transition in metazoans and a major target
of the tumor suppressor Rb [10][11]. The mechanisms
controlling E2F activity have not been completely eluci-
dated. E2F is activated toward the end of G1 and it func-
tions to promote S phase. Nonetheless, E2F is inactivated
and/or downregulated upon progression to S phase, a reg-
ulatory feature that appears critical as E2F overexpression
or ectopic activation induces apoptosis both in mamma-
lian cells and in flies [12][13][14][15]. Inactivation of the
DNA-binding activity of E2F-1 by the cyclin A/Cdk com-
plex has been shown to be critical for proper S phase pro-
gression [16]. In mammalian cells, E2F-1 is also subject to
proteasome-mediated degradation [17][18][19] and
recent evidence indicates that E2F-1 degradation occurs in
S phase [20]. Control of E2F-1 stability has also been
linked to its association with the F-box protein Skp2 [20]
but this has not been tied to a specific phase of the cell
cycle. In addition, Skp2 knock-out cells do not accumu-
late E2F [21] and an E2F mutant unable to bind Skp2 is
still ubiquitinated and unstable [21]. Thus, the basis of S
phase destruction of E2F-1 remains unresolved. Analysis
of E2F levels in the Drosophila eye disc showed a disap-
pearance of E2F staining in the S phase cells of the mor-
phogenetic furrow, suggesting conservation of the S phase
destruction of this regulator [12].
To explore potential roles for Cul1 in cell cycle control in
D. melanogaster, we overexpressed mouse Cul1 (mCul1)
in the wing imaginal disc and found that this overexpres-
sion has a dominant negative effect leading to a reduction
in SCF function. A screen for modifiers of the resulting
small wing phenotype identified E2F as a putative target
of SCF action. Further analysis of genetic interactions
implicated the SCFSlimb complex as a regulator of E2F
function.
Results
Mouse Cul1 overexpression in Drosophila leads to 
reduced SCF function
Since genes encoding highly conserved activites often
function across species boundaries, we attempted to eval-
uate mouse Cul1 (mCul1) function in Drosophila. To this
end, we used a GAL4 transgene to drive overexpression of
mCul1 in the wing disc. MS1096 is an X-linked transgene
that expresses GAL4 strongly on the dorsal surface and
more weakly on the ventral surface of the wing primor-
dium in third instar larval wing imaginal discs. Because of
dosage compensation, GAL4 levels in males (MS1096/Y)
are twice those in heterozygous females (MS1096/+). In
males (MS1096/Y;UAS-mCul1/+), mCul1 overexpression
led to a strong reduction in the size of the wing without
any gross patterning defects (fig. 1A,1B). Females
(MS1096/+;UAS-mCul1/+) displayed a weaker phenotype
that was sometimes indistinguishable from wild-type (see
fig. 2A). In males, further increasing expression by using
two copies of the UAS-mCul1 transgene reduces the wing
to a rudimentary stump (not shown). The reduced wings
also occasionally showed a multiple wing hair phenotype
in which several trichomes instead of just one were pro-
duced by individual intervein cells, particularly in the
region near the anterior cross-vein. Introduction of a sin-
gle mutant copy of the Cul1k01207 allele [22] or a deficiency
that uncovers Cul1 (Df(2R)NCX8) dominantly enhanced
the wing reduction (fig. 1C). In contrast, decreasing the
level of endogenous Cul3/guftagu (another Cullin family
member, see http://flybase.bio.indiana.edu/) or express-
ing a GFP marker had no effect. Coexpression of Dro-
sophila Cul1 (dCul1) suppressed the phenotype induced by
expression of mCul1 (fig. 1D). These data show that over-
expression of mouse Cul1 has a dominant negative effect
on Cul1 function, or that dCul1 suppresses a neomorphic
activity of mCul1.Page 2 of 12
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Dominant negative effect of mCul1 overexpression 
in the wing. (A) Wild-type wing expressing only the GAL4 
driver (MS1096/Y). (B) Wings overexpressing mCul1 using 
the MS1096 GAL4 driver (MS1096/Y;UAS-mCul1/+) are 
smaller than wild-type. (C) When endogenous levels of Cul1 
are reduced by introduction of a mutant allele of Cul1 
(MS1096/Y;Cul1k01207/+;UAS-mCul1/+), wing reduction is 
enhanced. (D) Co-expression of fly Cul1 (MS1096/Y;UAS-
mCul1/UAS-dCul1) rescues wing size to a phenotype indistin-
guishable from fly Cul1 overexpression alone (not shown). 
All wings in this and subsequent figures are at the same mag-
nification. Scale bar is 1 mm.
Figure 2
mCul1 overexpression leads to a reduction in SCF 
function. (A) Moderate overexpression of mCul1 (MS1096/
+;UAS-mCul1/+) gives a weak phenotype that sometimes 
overlaps wild-type. (B) The presence of a deficiency that 
removes one copy of both dSkpA and dRoc1 (MS1096/
T(1;Y)B106;UAS-mCul1/+) strongly enhances the reduction in 
wing size. (C) Wing with a strong phenotype (MS1096/Y;UAS-
mCul1/+). (D) Co-expression of dSkpA (MS1096/Y;UAS-
mCul1/UAS-dSkpA) partially restores wing size. (E) Reducing 
proteasome function by introduction of a dominant negative 
allele of a proteasome subunit (MS1096/Y;UAS-mCul1/DTS7) 
enhances the phenotype. (F) Full length Ci level in MS1096 
wing disc. (G) Increased level of full length Ci in MS1096/
Y;UAS-mCul1/+ wing disc. In F and G, Ci is detected by 
immunofluorescence. The outline of the posterior part of the 
disc (that does not express Ci) is shown by the dashed line. 
The solid line indicates the wing pouch region where GAL4 
expression is strongest.Page 3 of 12
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age of other SCF components, we asked whether changing
the copy number of both dRoc1 and dSkpA can modify the
mCul1-induced phenotype. dRoc1 and dSkpA are located
at the tip of the X chromosome in region 1B (Flybase,
http://flybase.bio.indiana.edu/). The small wing pheno-
type seen in flies overexpressing mCul1 was enhanced
when flies also had a deficiency uncovering this region
(fig. 2A,2B), while coexpression of dSkpA rescued the
wing phenotypes (fig. 2C,2D). These results show that
SCF function limits the mCul1 overexpression phenotype.
Cul1 and SCF function are required for proteasome-
dependent degradation of a number of proteins in other
organisms. We thus tested whether reduction in proteas-
ome function would modify the phenotype caused by
mCul1 overexpression. The DTS5 and DTS7 alleles are
mutations in the β6 and β2 subunits of the proteasome
[23][24]. Both mutations, which have antimorphic activ-
ity, acted dominantly to strongly enhance the small wing
phenotype generated by mCul1 overexpression (fig. 2E)
supporting the idea that the phenotype is due to reduced
degradation of an SCF substrate.
To directly assess Cul1 function, we sought a target pro-
tein whose destruction might be limited by the activity of
the Cul1/proteasome pathway. While SCF triggers ubiqui-
tination and proteasome action degrades many substrates
to completion, a few targets are instead cleaved and par-
tially degraded. This is true of the transcription factor
Cubitus interruptus (Ci): it is cleaved and its C-terminal
portion is degraded [25][26][27]. Cleavage and degrada-
tion require phosphorylation, SCFSlmb, and proteasomal
activity. While complete inactivation of SCFSlmb causes cell
death, it was shown that a cell-viable hypomorphic slimb
allele resulted in accumulation of unprocessed Ci. Based
on this, and findings that Ci accumulation is especially
sensitive to pharmacological inhibition of the proteasome
(data not shown), it appears that Ci levels are particularly
sensitive to partial reduction in the activity of the SCF/
proteasome pathway of protein processing/degradation.
Inhibition of Ci processing can be scored by the accumu-
lation of a C-terminal epitope [26]. This assay showed
that reduction in the function of Slimb or Roc1, two activ-
ities that contribute to SCF function, is associated with an
increase in Ci staining [26][27]. Similarly, reduction of
Cul1 function by mutation in Cul1 (data not shown and
[28]) or by overexpressing mCul1 (fig. 2F and 2G) led to
Ci accumulation.
Together these results indicate that mCul1 overexpression
leads to a Cul1 dominant negative action that reduces SCF
function. Based on the strength of the phenotype and its
enhancement by removal of an endogenous copy of Cul1,
we infer that the mCul1 expression only partially
suppresses Cul1 function to create a hypomorphic pheno-
type. We infer that the wing defect results from a reduction
in the rate of degradation of one or more targets of SCF
action.
Reduction in Cul1 function induces apoptosis
The reduction in wing size in mCul1 overexpressing flies
could result from changes in cell size or cell number. Each
cell of the wing blade produces a hair and hair density
indicates cell density and hence cell size. Wing hair den-
sity was unchanged by mCul1 expression, even when
there was a dramatic effect on wing size (62.6 ± 3.0 cells/
7950 µm2 for MS1096/Y; 60.8 ± 2.3 cells/7950 µm2 for
MS1096/Y;UAS-mCul1/+). This result suggests that mCul1
overexpression causes a reduction in cell number either by
a coordinate reduction in cell growth and proliferation or
by increasing cell death. To distinguish between these pos-
sibilities, we dissected wing imaginal discs from late third
instar larvae and stained them for mitotic or apoptotic
cells. Labelling with an anti-phospho-histone 3 antibody
did not reveal any significant changes in the number of
mitotic cells (not shown). However, acridine orange stain-
ing showed a large increase in cell death throughout the
wing pouch when mCul1 was overexpressed (fig. 3A,3B).
Coexpression of baculovirus anti-apoptotic protein p35
rescued the reduction in wing size (fig. 3C,3D) indicating
that mCul1 overexpression induces elevated apoptosis.
mCul1-induced apoptosis was insensitive to the coexpres-
sion of dominant negative forms of p53 (not shown). p35
expression also suppressed the multiple wing hair pheno-
type indicating that this phenotype too requires apopto-
sis. As dead cells do not contribute to adult structures, this
phenotype must be a secondary consequence of cell
death. We conclude that limiting SCF function induces
apoptosis. Note that this conclusion does not argue
against a cell cycle role for SCF, as defects in cell cycle pro-
gression can trigger apoptosis.
Dominant negative mCul1 genetically interacts with E2F
Having determined that the mCul1 overexpression phe-
notype results from a dominant negative effect, we were in
a position to test for genetic interactions between mCul1
overexpression and mutations in potential cell cycle tar-
gets of Cul1. Because SCF complexes have been impli-
cated in cell cycle control in other organisms, we tested
whether changing the dosage of cell cycle regulators dom-
inantly modified the mCul1 overexpression phenotype.
Reductions in the levels of a variety of cell cycle genes –
cyclin E, dacapo, roughex, DP, RBF, string, cyclin A, rca1,
wee1 and cdc2 – had no effect on wing size (not shown).
In contrast, reducing the level of E2F by 50% completely
restored wild-type wing size (fig. 4A,4B,4C), an effect that
correlated with a strong reduction in cell death in the disc
(fig. 4E,4F). The presence of a single hs-E2F transgene gave
a weak and incompletely penetrant enhancement in thePage 4 of 12
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Reduction in Cul1 function causes apoptosis. (A) Wild-
type third instar wing discs stained with acridine orange 
show very little cell death. (B) Discs with reduced Cul1 func-
tion due to mCul1 overexpression have a high level of cell 
death. (C) Small wing phenotype due to mCul1 expression 
(MS1096/Y;UAS-mCul1/+). (D) Partial suppression when the 
anti-apoptotic protein p35 is co-expressed (MS1096/Y;UAS-
mCul1/UAS-p35).
Figure 4
Dominant negative Cul1 interacts with E2F. (A) Wild-
type wing. (B) Small wing due to dominant negative Cul1 
expression (MS1096/Y;UAS-mCul1/+). (C) This phenotype is 
completely suppressed when E2F levels are reduced by 50% 
(MS1096/Y;UAS-mCul1/E2F91). (D) Increased levels of E2F 
from a transgene under the control of the HSP70 promoter 
enhance the small wing phenotype (MS1096/Y;UAS-mCul1/hs-
E2F) after heat shock treatment. (E) Discs overexpressing 
mCul1 have a high level of cell death (MS1096/Y;UAS-mCul1/
+). (F) Cell death is reduced when E2F levels are reduced 
(MS1096/Y;UAS-mCul1/E2F7172).Page 5 of 12
(page number not for citation purposes)
BMC Genetics 2003, 4 http://www.biomedcentral.com/1471-2156/4/9absence of heat shock, and this enhancement was stronger
and completely penetrant when the transgenic strain was
exposed to a heat shock treatment every 24 h during third
instar and early pupal development (fig. 4D). Since the
presence of the hs-E2F transgene and its induction by our
heat shock protocol (low level overexpression compared
to Asano et al., 1996) had no phenotype when in a wild-
type background, we conclude that mCul1 expression sen-
sitizes the cells to E2F overexpression. The reciprocal sup-
pression by E2F mutation and enhancement by E2F
overexpression show that the apoptosis triggered by
mCul1 is mediated by or requires E2F function. Because a
high level of ectopic expression of E2F is known to induce
apoptosis [12][13], these results suggest that mCul1 over-
expression might interfere with normal E2F
downregulation.
Dominant negative Cul1 expression disrupts E2F inactiva-
tion in S phase
Immunostaining for E2F in the furrow of the eye disc
showed an abrupt drop in protein levels at the position
where most cells exit G1 and initiate S phase [12]. Using a
double label approach, we were able to test directly for
overlap between E2F presence and S phase as marked by
5-bromodeoxyuridine (BrdU) incorporation in dividing
cells of the wing disc despite the asynchrony of division.
No E2F staining was detected in BrdU labelled cells
(green) of wild-type wing discs, whereas non-S phase cells
showed strong E2F (red) staining (fig. 5A, 5B, 5C) (no E2F
staining was observed in over a thousand BrdU positive
cells from 8 different discs). Thus, E2F is downregulated in
advance of significant BrdU incorporation in wild-type
wing disc cells.
When mCul1 is overexpressed, a small fraction of S phase
cells (3% of 800 BrdU positive cells from 6 independent
wing discs) contains detectable amounts of E2F (fig. 5D,
5E, 5F, arrowheads). Since E2F is normally degraded prior
to S phase, the overlap in staining suggests that the partial
suppression of Cul1 caused by mCul1 expression slowed
E2F destruction to the point that it persisted briefly in S
phase. We suggest, but have not demonstrated, that the
low percentage of cells showing the overlap in the staining
is due to a remaining capacity of the residual SCF activity
to promote slower but still effective elimination of E2F
during S phase. In any case, our finding shows that when
dCul1 function is reduced, the normal pattern of E2F deg-
radation in S phase is disrupted, leading to inappropriate
persistence of E2F. While it could also be suggested that
this effect might be secondary to other disruptions
induced by dominant negative Cul1, the genetic suppres-
sion of phenotypes by reduction of E2F dose (above) sug-
gests otherwise, as do the analyses of the role of the F-box
protein, Slimb (below).
Slimb is required for E2F downregulation in S phase
The experiments described above demonstrate that over-
expression of mCul1 produces a phenotype that can be
modified by second site mutations and therefore could be
used for a more general genome-wide modifier-screen. To
determine whether other suppressors or enhancers might
be isolated, we tested if deficiencies on the third chromo-
some uncover other potential interacting genes.
One modifying deficiency, Df(3R)e-R1, removes region
93B6;D3-4 and acts as an enhancer of the small wing phe-
notype. One gene in this region, slimb, is an interesting
candidate because this gene encodes an F-box protein that
is part of an SCF complex [26][29]. Several independent
alleles of slimb were tested and all enhanced the domi-
nant-negative mCul1 overexpression phenotype (fig. 6,
compare A and B). Four deficiencies uncovering other pre-
dicted F-box containing genes (CG4911, CG3428,
CG2010 and CG9003) or mutations in the F-box protein
genes ppa and ago [30][31] had no effect on the phenotype
(not shown) showing that the effect is specific. Interest-
ingly, co-reduction of E2F and slimb function reversed the
slimb enhanced mCul1 overexpression phenotype (fig. 6A
and 6C) and loss of a copy of slimb attenuated the suppres-
sion of the mCul1 phenotype resulting from loss of one
copy of E2F (compare fig. 4C and 6C). This mutual co-
suppression suggests that slimb and E2F exert opposing
activities on the same process and perhaps that Slimb acts
on E2F or on a critical regulator of E2F activity.
We thus wished to test whether loss of Slimb had an effect
on E2F protein in imaginal discs. As slimb null mutants die
as first instar larvae, direct analysis of the mutant discs was
not possible. The severity of the slimb mutant phenotype
Figure 5
Dominant negative Cul1 impairs E2F inactivation in 
S phase. Third instar discs were labelled for BrdU to detect 
S phase cells (green) and for E2F (red). (A-C) Wild-type wing 
disc. (D-F) mCul1-overexpressing wing disc. No overlap is 
seen in wild-type whereas there is overlap (arrowheads in F) 
in some cells that overexpress mCul1. Scale bar is 5 µm.Page 6 of 12
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much more than did expression of mCul1. We used a
slimb mutant stock carrying a slimb transgene under the
control of the HSP 70 promoter to modify the time of
onset of the slimb mutant phenotype. In the absence of
heat shock, slimb homozygotes exhibited the early
lethality of slimb mutants, but a single 30 minute heat
shock at 37°C during first instar was enough to allow
some larvae to reach the wandering third instar stage 4
days later. These larvae have small imaginal discs. Label-
ling of these discs with the anti-E2F antibody revealed that
Figure 6
Interactions with slimb. (A) Control (MS1096/Y;UAS-
mCul1/+). (B) slimb mutations are dominant enhancers 
(MS1096/Y;UAS-mCul1/slmbe4-1). (C) A chromosome bearing 
mutations in both slimb and E2F has no effect on the pheno-
type (MS1096/Y;UAS-mCul1/slmbP245E2F7172).
Figure 7
slimb mutant cells accumulate E2F in S phase. (A-C) 
slmb8, hs-slmb disc cells without heat shock, (D-F) slmb8, hs-
slmb disc cells 1.5 hour after a heat shock restoring Slimb 
expression. E2F is in red, BrdU in green. C and F show 
merged images of A and B and D and E respectively. Aster-
isks point to cells with high BrdU incorporation that still 
express E2F. Scale bar is 5 µm.
Figure 8
E2F mRNA does not accumulate in slimb mutant 
discs. (A) Wild type wing disc and (B) slmb8, hs-slmb wing 
disc hybridized with a digoxygenin labelled E2F probe and 
detected by an indirect fluorescent staining method [42]. The 
disc from the slimb mutant is much reduced in size but in all 
cases examined, it showed an hybridization signal comparable 
to the wild-type disc.Page 7 of 12
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also incorporated low levels of BrdU (fig. 7B and 7C), usu-
ally in regions of the nucleus with lower E2F staining. A
few cells also had high levels of BrdU incorporation and
these also expressed E2F, although at lower levels (aster-
isks on fig. 7A and 7B). An hour and a half after a heat
shock that restored Slimb expression, BrdU-labelled cells
no longer contained detectable levels of E2F (fig.
7D,7E,7F). No accumulation of E2F mRNA can be seen in
slimb mutant discs (fig. 8) suggesting that any effect of
Slimb on E2F occurs posttranscriptionnally. These results
indicate that elimination of E2F during DNA replication
requires Slimb.
Slimb and E2F interact in vitro
The above results raise the possibility that an SCFSlmb com-
plex can target E2F for degradation. If this is the case, it is
expected that Slimb would recruit E2F to the complex. To
test this hypothesis, we asked whether Slimb and E2F
physically interact. To this end, 35S-labelled E2F was
produced in vitro in a wheat germ lysate and incubated
with the WD repeat region of Slimb fused to GST and
bound to beads. Analysis of bead associated proteins (fig.
9) showed association of radiolabeled E2F with the fusion
containing the WD-repeat region of Slimb (lane 3) but
not with GST (lane 2). The interaction between Slimb and
E2F depends on a phosphorylation event as it is prevented
by the presence of active alkaline phosphatase (lane 4)
but not when the phosphatase is inhibited by sodium
vanadate (lane 5). Similar results were obtained with
E2F2, the other Drosophila E2F family member (not
shown).
Discussion
We have provided evidence indicating a role for an SCF-
Slmb complex in elimination of E2F during S phase in Dro-
sophila. We first demonstrated that mouse Cul1
overexpression has a dominant negative effect on SCF
function in the wing imaginal disc resulting in apoptotic
cell death leading to a small wing phenotype in adult flies.
Thus, SCF activity normally suppresses cell death. The cell
death that occurred upon reduction of Cul1 function was
suppressed when E2F function was reduced by mutation.
This genetic interaction might be due to action of E2F and
Cul1 in parallel pathways, one suppressing and one
enhancing cell death, or they might act in opposite direc-
tions in the same pathway. Because SCF complexes are
involved in controlling protein degradation, we favoured
the hypothesis that Cul1 promotes the destruction of E2F
and that the inappropriate persistence of E2F leads to cell
death. Consistent with this idea, E2F overproduction can
induce apoptosis [12][13]. Furthermore, cell cycle specific
destruction of E2F was suggested by the finding that E2F
protein becomes undetectable in the synchronised S
phase cells of the morphogenetic furrow of the eye imagi-
nal disc [12]. Our double labelling analysis extended this
finding to the asynchronously cycling cells of the wing
imaginal disc and demonstrated that E2F is rapidly
degraded prior to significant DNA replication. In contrast,
we found that E2F was detected in a fraction of S phase
cells when SCF function was reduced by mCul1. This
shows that normal E2F downregulation is delayed or
slowed by reduction in SCF function.
Although the dominant negative action of mCul1 in Dro-
sophila was unanticipated, it offers a fortuitously
convenient tool for the analysis of SCF function. The Dro-
sophila Cul1 mutant is less useful because maternal contri-
butions of Cul1 are so large that homozygous mutant
animals develop to pupariation. Additionally, unlike the
spatially restricted expression of mCul1, the strong Cul1
mutant alleles result in lethality. The stage and generality
of the defects make analysis of the Cul1 mutant pheno-
type particularly difficult. In contrast, the induced expres-
sion of mCul1 in the wing disc does not compromise
viability and it gives a distinctive graded phenotype well
suited for the study of genetic modification. While the
basis for the dominant negative effect of mCul1 remains
unknown, it is important to recognize that inactivation of
the endogenous Cul1 is incomplete so that a reduced level
of Cul1 activity persists. One likely explanation for the
negative effect is that mCul1 overexpression leads to
sequestration of some limiting SCF components into
weakly active complexes. This hypothesis is consistent
with the fact that mCul1 retains some positive function in
flies as revealed by its ability to prolong survival of dCul1
Figure 9
Slimb and E2F associate in vitro. GST-Slimb(176–510) 
can interact with E2F (lane 3) but not with another protein 
(luciferase, lane 1). GST alone does not interact with E2F 
(lane 2). Treatment of E2F with active alkaline phosphatase 
prevents binding to Slimb (lane 4). Binding is restored in the 
presence of the phosphatase inhibitor Na3VO4 (lane 5).Page 8 of 12
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lished data).
The essentially complete suppression of the mCul1 phe-
notype by reduction of the genetic dose of E2F suggests a
remarkable level of specificity, in which, among the many
targets of Cul1 action, the destruction of E2F appears to be
particularly important. Similarly, limitations of Cul1
function in other organisms also uncovered the dispro-
portionate importance of particular substrates. For exam-
ple, Cul1 mutations in mice result in the accumulation of
the SCF substrate cyclin E but not of p27 another well
characterized SCF substrate [32]. Among all of the sub-
strates targeted for degradation by SCF in S. cerevisiae, it is
the failure to degrade Sic1 that underlies the G1 arrest in
cdc53 mutants [3][4]. Thus, different substrates of the SCF
appear to have particularly high dependence on SCF activ-
ity in different biological contexts. We suggest that our
experimental context using mCul1 expression in the wing
disc is particularly effective in exposing the involvement
of SCF in E2F destruction.
Since SCF complexes function in conjunction with a vari-
ety of F-box proteins that act as specificity factors, muta-
tions in individual F-box proteins ought to affect
particular subsets of SCF substrates. In an extensive screen
for loci that modify the reduction of function phenotype
for Cul1, we identified the gene encoding the F-box pro-
tein Slimb as a modifier, and we failed to detect contribu-
tions of other F-box encoding genes to the phenotype.
This implicates Slimb in the action of SCF on E2F. Analy-
sis of E2F levels revealed that cell cycle oscillations in E2F
levels were absent when Slimb function was severely
reduced. Note that the severity of this E2F destruction
phenotype in comparison to the mild defect in cell cycle
programming of E2F destruction upon mCul1 expression
is entirely consistent with the fact that the slimb mutant
gives a stronger loss of function than the reduction of
function imposed by mCul1 overexpression. The absence
of cell cycle oscillation in E2F presence in the slimb mutant
suggests that SCFSlmb is responsible for targeting E2F for S
phase destruction. If this destruction is the consequence
of direct action of SCFSlmb on E2F, we would expect the F-
box protein to interact with E2F. We confirmed this pre-
diction by pull-down experiments. Furthermore, we dem-
onstrated that the interaction between Slimb and E2F is
dependent on phosphorylation, as expected for the inter-
action of F-box proteins with their substrates. We suggest
that the S phase specificity of E2F destruction is regulated
by a targeting phosphorylation event, but we have not yet
investigated this level of the regulation.
While SCF was previously implicated in the destruction of
E2F-1 in mammals [20], this earlier study appears to focus
on a distinct action of SCF. The starting point for the
analysis was an interaction between E2F-1 and Skp2, an F-
box protein that is not the mammalian homolog of Slimb.
Mutations of E2F-1 that disrupted this interaction
increased E2F-1 stability in transfection experiments.
However, there was no demonstration that this interac-
tion was involved in or required for cell cycle oscillations
in the level of E2F-1. Furthermore, Skp2 knockout cells
show no defect in E2F-1 degradation [21], and E2F-1
proteins unable to interact with Skp2 are still unstable
[20]. Our results implicate SCFSlmb rather than SCFSkp2 in
cell cycle specific destruction of E2F and argue that this
regulation is critical for cell viability at least in flies. As a
unifying view, we propose that Skp2-mediated control
and Slimb-mediated control of E2F activities occur at dif-
ferent times during the cell cycle and that SCFSlmb is
responsible for the rapid destruction of E2F in S phase.
Since E2F is a positive regulator of the G1/S transition, it
is not clear why S phase destruction of E2F is required.
However, we note that slimb mutant cells do not replicate
DNA normally and the replication defect is correlated
with an increase in E2F in individual cells. This
observation is consistent with previous reports indicating
that E2F can limit DNA replication both in mammalian
cells [16] and in flies [33]. This enigmatic feature of E2F
regulation suggests that its continued presence has a neg-
ative effect on DNA replication and indicates that we still
have much to learn about its roles in cell cycle regulation.
SCFSlmb appears to influence other cell cycle events, per-
haps by actions on other substrates, or perhaps as a result
of events that are secondary to its influence on E2F
destruction. For example, a slimb allele shows defects in
centrosome duplication control [34], and slimb null cells
undergo apoptosis [35]. Both effects could be explained
by a failure to inactivate E2F, as E2F promotes centrosome
duplication in mammalian cells [36] and E2F can induce
apoptosis [12][13]. A link between Slimb function and
the RB/E2F pathway of cell proliferation control is also
suggested by the genetic interaction between the C. elegans
slimb ortholog lin-23 and the RBF ortholog lin-35 in which
lin-35 function limits the severity of the loss of lin-23 [37].
Since RBF is an important modifier of E2F activity, per-
haps this interaction is a reflection of the action of both
Lin-23 and Lin-35 on E2F. However, in our experimental
situation, we did not observe any modification of the
mCul1 overexpression phenotype by mutations in either
the RBF or DP gene, two known partners of E2F. This
result suggests that these factors are not limiting factors in
this situation or that E2F acts independently of RBF and
DP. The latter hypothesis is the most likely explanation
for the lack of an RBF interaction for the following reason.
The E2F/RBF complex has to be disrupted for E2F to drive
cells into S phase and E2F degradation occurs after the G1/
S phase transition which only happens after E2F has beenPage 9 of 12
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view, we would predict that the mCul1-induced pheno-
type should be specifically sensitive to factors impinging
on the elimination of E2F activity during S phase, and fac-
tors involved in the unknown processes by which persist-
ence of E2F has negative outcome. Consequently, this
experimental system may provide an avenue for the
genetic dissection of this mysterious facet of E2F function.
Conclusions
To explore potential roles for Cul1 in cell cycle control in
D. melanogaster, we overexpressed mouse Cul1 (mCul1)
in the wing imaginal disc. We found that this overexpres-
sion has a dominant negative effect leading to a reduction
in SCF function. We used the resulting small wing pheno-
type in a modifier screen to identify mutations in cell cycle
genes capable of dominantly modifying the mCul1-
induced phenotype. We found that E2F loss-of-function
mutations were the strongest modifiers as they completely
suppressed the phenotype. The reduction in SCF function
associated with mCul1 overexpression also correlated
with a failure to downregulate E2F normally in S phase.
Additionally, mutations in slimb that reduced the function
of the F-box protein Slimb enhanced the phenotype and
led to persistence of E2F in S phase cells. Finally, this F-
box protein interacts with E2F in vitro. These results indi-
cate that an SCFSlmb complex is involved in regulating E2F
activity during S phase.
Methods
Identification of fly Cul1 and Skp1 orthologs
We identified several lead ESTs in the Berkeley Drosophila
Genome Project database. Sequencing of one of the corre-
sponding cDNAs (LD20253, obtained from Genome Sys-
tems Inc., St. Louis, MO) revealed that it encodes a protein
with 61% identity to the mouse and human Cul1 pro-
teins. Expression of this cDNA in yeast is able to rescue the
cdc53-1 mutation (not shown) indicating that the protein
can perform at least some of the functions of the yeast
Cul1. We used the same strategy to identify a Skp1 cDNA
that also rescues skp1 mutations in yeast (not shown).
Because the Drosophila genome contains several Skp1-
like genes, we call the fly Skp1 homologue dSkpA.
Stocks
UAS-mCul1, UAS-dCul1 and UAS-dSkpA were generated
by subcloning the coding region of the corresponding
cDNA in pUAST [38]. The resulting vectors were then used
to transform y1w67 embryos. The MS1096 stock is as
described [39]. The Cul1 allele k01207 [22] will be
described elsewhere. The following mutations were tested
for genetic interaction with mCul1 overexpression:
E2Frm729, E2F91, E2F7172, cycAC8LR1 (a gift from Christian
Lehner), cycAneo114, cycEAR95, stg7B, stgAR2, cdc2B7, cdc2E1–9,
DPvr10–13, Df(2R)vg56, Dwee1ES1 (a gift from Shelagh
Campbell), Df(2L)WO5, gft1, gft6430 (gifts from Hemlata
Mistry), rca103300, rca12, dap3X1, DTS5 and DTS7 (gifts
from John Belote). The Bloomington Stock Center
(Bloomington, IN; http://flystocks.bio.indiana.edu/) pro-
vided the l(2)k01207 and T(1;Y)B106 stocks and the defi-
ciency kit for the third chromosome. The Umeå Stock
Center (Umeå, Sweden) provided the Df(2R)NCX8 stock.
UAS-p35 and UAS-PI3KD954A were given by Bruce Edgar
and Michael Waterfield, respectively. Slimb alleles were
provided by Tian Xu (slmbe4-1) and Bernadette Limbourg-
Bouchon (slmbP245, slmb8 and slmb8, hs-slmb).
Genetic interaction tests
For modification of the mCul1 overexpression pheno-
type, MS1096; UAS-mCul1/TM3,Sb virgin females were
crossed to males bearing the tested mutation or transgene
over a marked chromosome (L or If for the second chro-
mosome, TM3,Sb or TM6B for the third chromosome)
and males from the progeny were inspected for modifica-
tion of the phenotype. All crosses were kept at 25°C. The
wings of all MS1096; UAS-mCul1/+ flies reach the tip of
the abdomen and all modifiers are highly penetrant. A
mutation was considered an enhancer if the wings were
significantly shorter and a suppressor if they were clearly
longer. Mutations on the X chromosome were first recom-
bined with MS1096 and interactions were tested in
females by crossing MS1096/Y;UAS-mCul1/TM3 males to
virgin females carrying the mutation and MS1096 over a
balancer. As a control, MS1096;UAS-PI3KD954A/TM3 vir-
gin females were crossed to males bearing modifiers of the
mCul1 phenotype. Modifiers that had the same effect on
both the mCul1 and the dominant negative PI3K pheno-
types were discarded as they presumably affected the
GAL4 driver. Wings were dissected and mounted in glyc-
erol/ethanol (1:1) and pictures were taken under
brightfield illumination on a Leica microscope equipped
with a CCD camera. Heat shock treatments consisted of
two 10 minutes incubations at 37°C separated by a 20
minutes interval at 23°C. Cell size was assessed by
counting trichomes in a 7950 µm2 area on wings from 10
different flies.
Imaginal discs staining
For acridine orange staining, discs were dissected in Sch-
neider's medium, incubated for 5 minutes in medium
containing 1.6 × 10-7 M acridine orange, washed briefly
and put on a slide in a drop of medium. Pictures were
taken immediately. For E2F/BrdU double staining, discs
were first incubated 30 minutes in a drop of Schneider's
medium containing 10% fetal calf serum and 1 mg/ml
BrdU then fixed 20 minutes with 2% formaldehyde in PLP
(10 mM NaIO4, 75 mM Lysine, 37 mM NaH2PO4, pH
7.2). Fixed discs were then permeabilized in PBS contain-
ing 0.1% saponin and 1% goat serum and incubated
overnight with an anti-E2F serum [12] at 1/250. TwoPage 10 of 12
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the tyramide biotin system (NEN) were used to detect
E2F. Following this, the discs were processed for BrdU
detection as previously described [40]. Images were taken
with a Princeton Instruments CCD camera on an Olym-
pus inverted microscope using the DeltaVision micros-
copy system software. Cubitus interruptus was detected
using the rat monoclonal antibody 2A1 [41]. To compare
protein levels, control and mCul1-expressing discs were
processed together. E2F mRNA was detected by in situ
hybridisation using an antisense probe as described [42].
A sense probe used as control gave no signal. To compare
levels, discs were processed together.
In vitro interaction test
Plasmid pGEX4T1-Slmb(176–510) allowing expression
of fragment 176–510 of the Slimb protein fused to GST
was kindly provided by Anne Plessis and Matthieu Sanial.
GST fusion proteins were purified from Escherichia coli
BL21 as described [43], except that bacteria were grown at
30°C. In vitro translated (IVT) proteins were produced
and radiolabelled with 35S-methionine using the TNT
coupled wheat germ extract system from Promega. IVT
proteins were incubated with the GST fusion proteins on
beads for 1 hour at 4°C in 500 µL of 40 mM HEPES pH
7.4, 100 mM KCl, 5 mM MgCl2, 1 mM EDTA, 1% Triton
X100, 1 mM ATP, 1 µM microcystin, 14 mM b-mercap-
toethanol. For phosphatase treatment, IVT proteins were
first incubated in 130 µl of binding buffer containing 20
U of alkaline phosphatase in the presence or absence of 10
mM Na3VO4 for 1 h at 37°C. After incubation, beads were
then washed three times with incubation buffer contain-
ing 130 mM KCl. Bound proteins were then analysed by
SDS-PAGE and autoradiography.
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